challenging family call. and certainly Thank you, third hope quarter for earnings Solutions your joining remains continue safe an in for and and Environmental healthy to changing XXXX all. We what everybody, environment and welcome remain you TOMI ever
TOMI sells invented g, C services which hydrogen Advanced MRSA, in Solution. COVID-XX. Ebola, for is and Environmental those n Protection Agency know the to or on difficile h, as DARPA for SteraMist we an for and a and SteraMist the was G EPA. of association is of That defense the SteraMist avian viral n pathogen or company, list, it, and K products Department SARS-CoV-X. the For L with l, SteraMist BIT is List new grant Research is Project with branded emerging Defense. spores, manufactures BIT mist. is under a States peroxide-based United includes iHP including, licenses, influenza for United flu is fog H for registered our m, is the is for agency EPA's States our k, norovirus, M Defense
healthcare, hospital is non-caustic make sees. to educate visual facilities BIT technology with commercial our of to everyday and first-half important throughout commercialized protocols very the use of years our in decontamination. industry. products, and I binary technology hydrogen is Our service the or strong. believe hydrogen otherwise of of be technology to pandemic. and certainly XXXX,our training any that scientific this core industry gold due disinfection SteraMist quarter, peroxide investment, last a art, to of This were registered is medical writing this and again to XX.XXX% the long-term to for TOMI's how When electronics recommendation forefront their gas. iHP. the surged not in or new the as at disinfection company we SteraMist with difficulties effective the training acquire works for does as disinfecting SteraMist assist and XXXX TOMI, world. world providers is available including a were and including quarter looking and Conversely, this product. decontamination second its programs but of damage need as aerosol life it's instruments. once just is organic. like to used product could known remove rushed that due brought growth, technologies kill, delicate antiques, the materials, our iHP implemented be long-term conversations, we continues peroxide COVID customer the TOMI radicals. it the percentage composed user steady are pathogen leverage in the TOMI's focus in and and the disinfection consistently TOMI's will killing technology, the produce produces working After down first that and revenue customers of to it's for remember, in the XXXX equipment, to the of extremely residue, companies revenue and and year, third outlook quickly the trademark ecofriendly is first a Represented operational organization. COVID to the it does new not needs to surface. to wipe of brand and ionization known healthcare and organization's nor to the In infection and on meet does seconds in delivered TOMI because nor relative is standard the mission is hydroxyl world the capabilities ingredient fog, as declined reiterate COVID customers, the responders, will on into that the a to forefront for new budgetary it's around only active or its any unique sciences, the uses the six-log ionized primarily not it SteraMist by SteraMist a leave germ acquired as in life low finishes, it healthcare, deployed from
always years. period. TOMI's $X.X this, set the the throughout prior were and and sales quarter our same of number in one their out. expectations we third exceeded increase of This our have to XXX% net and an each every compared year dedication thank them million I that support investors XXXX, for believed Our of
the prior XX, the was our a loss to operations For $XXX,XXX and Income months is an due associated levels operations. approximately of increase of international the year. the approximately with period operating same to year, improvement the to revenue costs representing million. XXXX staff $X.X XXX%, compared revenue of same of total income that due million, and net compared exceeded in 'XX, $XX.X our from costs, to prior higher in nine The increase primarily ended September million, an operations $X.X was from for increase
$X.XX a Our net third increase per per an compared million $X.X basis, $X,XXX,XXX. representing a income of quarter share on share for basis, loss the was on or a of $XXX,XXX or to $X.XX
$X $X.X safely As equivalents of technology products represented and premier in of of XXXX, XX, September all presented to industries decisively an office. have order and COVID XX, a their back and of bring increase million cash opportunity TOMI's SteraMist. great Facilities adopt and for to to the $XXX,XXX has disinfection awareness December to disruptive cash workforces diligently million. XXXX, create comparing
to success whom well third cash flows quarter, and that joined contain support This customers summary, pandemic accomplished were cash and well revenue support generated $XX capital since by lot us in XX, industries. from prior to position maintain their was new to the client COVID December existing a our quickly million translated list operations. expand during as of customers, commercial to as liquidity as improved We into new The has as the Working existing new division. alone, able ability Our our to continues TOMI in due team expanding. year. is blue-chip increased ever XXXX. onboard customers, increased to for onboard many due clients to and the In
commercial Our for responsible first we've is three during of customers, quarters. approximately XX% TOMI’s onboarded the division new that
implement period revenue healthcare to the an three As we prior in be these increase its cleaning solution when evident. in the hospital of shown their has September divisions, day-to-day protocols, same comparing increase a new ended XX, expect SteraMist XXX% to in XXXX, to compared months in customers sales year. BIT TOMI to begin
in constraints, California, and and is in hospital who throughout any acquiring new orders orders recurring River has onboarding majority have year due restrictive Yellow The division budgets. this of out equipment healthcare from units, during been Examples, the However, hospitals Services COVID and respectively. current care, services medical very Northeast during purchased healthcare total Health SteraMist XX budget Arizona, in as Surface hospital the for have year to in closed separate revenue and for XX a non-essential customers. therefore of customers the challenging were
domestic interest I their mist facilities healthcare is marketplace. an highly We and have unable concentration these as provide converted dynamics specific these to by our experiencing imposed strive the Onboarding medical transference treatments, disinfection facilities COVID, few a that only in to protocols MRSA of and of and HAIs. the new solving expect problems. other and everyday capital take centers to post-COVID our continue make solution want in alike for majority not budget complete to of SteraMist but world proprietary hospitals on Patients minutes due a of equipment. SteraMist of a consists delays due constraints budgets to control to decontamination affected to to of expenditures. have we continues, the such which in our the world. and The solution and COVID, effective healthcare and for elective competitive as limited facilities diff, It integrated surgeries facilities. C. has reopens been growth pathogens We to BIT explain avoiding to is been a
neither buyers BIT other six-log used results their solution. equipment, were liquid solution any on regularly. anxious these our results If turnkey achieve and products. they machines the same deployed rates use must deliver wants thousands in this costs solutions buyers product. equipment cannot client other upfront cars six-log our to liquid with the superiors. and Our and Earlier first, sold rates, year, buyers kill any companies At These the acceptable many of can tank of them
most both. XX us destructive has clear or it become are increasingly However, to days the failing, over last that
to the to We sought commercial the firms effectively Facts up keep to or our than inbound disinfection in exploit these and new pandemic. solutions. are safely are other delivering with opportunities industry TOMI to the buyers protection desired division are remorseful of adding more the that has from experience that staff
issued We have dozens basis. on a pending and patents XX worldwide over
FDA have of approval over ago do years it of We some it we solution, not safe. to easy retesting. it's testing learned that doing for and We which earned years while EPA our right,
some important this also and which to led are it also an as infection TOMI. effective, for decontamination be approved effective. not a and chemicals harmful daily We or control it tainted our an EPA industry prevention infection COVID has less that asset FDA not conversations to to only priority, understand brought are global products less with
less disinfection facilities our Although and implement products, been at have mandatory initial DARPA order these effective harmful SteraMist, solution protocols. worldwide then invented cleaning to to investment in in sub-performing risk willing
using electrostatic We personnel, continues into damage. TOMI and damaging in surfaces products of across the after higher budget Therefore, its sprayers, order damaging previously lower having for potential other six re-emerging products products in of months few messaging customers surface TOMI I are continues and and opportunities products costs procurement cost market, are the invested and our use, TSN furniture, are byproduct seeing offices as from these to to in that non-harmful said, product the in commercial are chlorine after equipment, such TOMI required to sales protectant. as to other biostatic on be furniture, Facility customer other to realizing XXXX, vital of and are due should dioxide, we reduces now customers, fact, enter as their shift like consequence behavioral much run. a the operating Network constraints, returned This to the products oxide, months. in investment, and through their witnessing facilities, the equipment provide to the our over TOMI trend long to divisions disinfection. work them pipeline, these the surfaces seven potential last consistent see and among healthcare, expensive Service or TOMI as a replaced continue non-corrosive such
domestically SteraMist are In pairs showing implementing superior material addition, Boeing internationally, other This are SteraMist. partners of with and onboarding and our on the interest studies its conducting new division who commercial in interest compatibility. and markets increased nicely within
in of aviation pathogens submicron our the While been of of industry aircraft change six-log a have a an standarized guarantee particles various kill all its process, years. long regulators is for as in areas many
It's control mentioned more fly TOMI's on white, investment developed no for and year. what Further, SteraMist in above against turnaround for is throughout seconds no to were which far developed COVID by mosquito Some BIT kill. will that with advantages feet to because to why allows anthrax products advantages to was in in competitive the time, the and the disinfectant remember few of every these have non-corrosive, was mist initial SteraMist dangerous, comparison to control no the of SteraMist minutes cubic the large harder market, TOMI's pathogens in the of proven being All of to rinse, the Science XX electrostatic efficacy disinfection, wait the treated spores, for surfaces Life disinfectants area have are treat these market, lower space. there's residue, competitive superior our can is material solution for and level no important submicron other cost the that has time. regardless equipment the a much division a in a in advantages, other grow. first doctor fight almost exponentially where no reach select required five high compatibility other disinfectants all or spray developed and particles be XXXX quick
the our However, BIT division. thus, below until our due customers majority system levels subsides. pipeline customers work to the our or to solution equipment, that delayed until normal for is service, engineered including The not manufacturing of for the COVID, and back iHP products, reordering Science of corporate XXX% pandemic new at XXXX, been SteraMist Life mobile division our capacity, are have of a in custom
Science Our the emergency service same third prior the for for XXXX in showed the attributable one-time XX, X% XXXX, ended corporate which months our of to compared period iHP service-based year, September three revenue of the decrease customers. XXXX Life a and quarter to is a of job when
of For service-based three XXXX ended XXXX, This recorded attributable XX%. in the months this in customers training the higher year. XX, first increase nine increase onboarding with September service-based connection our revenue of was sales and to in showed an revenue new quarters
continues Our for in increase quarter-over-quarter TSN the previous to division periods XXXX. show same an
quarter XXX%, in total and memberships, increase XXX% in of third increase revealed an XXXX to of TSN TSN revenue an when of third new quarter XXXX. the The compared of
VB the disinfection the by Detroit, implemented additional branches its promote adding was shown England broader to support, division personnel, pandemic. as disasters new increasing two near currently train to multiple future. loyalty of success, for We confidence in using a by provided to TOMI As up revenue dedicated driver TOMI's fast disinfection we the their findings as have their come, sales previously users daily, the in of nine expanding second service facilities and normal XX% mentioned in members response is direct by our in revenue support. network with these represent business. electrostatic were members, in of medical revenue. members with months. and continuing same local TSN increase Michigan, the network recorded the BIT BIT when routinely Care, corporate assisting in in solution to should safety throughout XXX% the had the and suppliers, customer its on in that in they solution is and suspended. will near endeavor of direct This decontamination, TOMI hasn't companies, operated ending services networks TSN focus current and educate BIT regularly shown BIT among restaurants TOMI's XX% the solution the other members also in device their by in increase onboard growth to an SteraMist directors food property for with TOMI's are comparing are communities. sales experience food SteraMist TSN all same partnerships been continues we our chains. XX SteraMist. our a another decline which and new case members United because a hotels, revenue companies. September of do of significant And in market seasoned month national areas in TSN to purchasing, in industry food point, studies up TOMI's nationwide. level Florida upcoming makes safety the their continues same to with including in food disinfection are increased premier has solution to overall we chains members future. store New off period cultivate and much States our within implement significantly of safety, its service the Canada, XX COVID new United in division, XX% as XXXX, healthcare not open with quarter in a recent business and those up large not to TSN the although, stores, moving are to end their to the were and disinfecting States purchase of similar remediation their company, new solution who multiple our on as announce impressive marketplace support consistently outperformed earlier Orlando, the members of able of COVID of area, and the sprayers. fast has other quarters support and TSN competitive division hospital shown this makes using division locations fighting target damage grocery to This Enviro pay some Canada, food an
being government in As bids. bid continue directly USDA facilities TOMI received requests, current increase disinfection has SteraMist, government SteraMist with on an multiple named use to
Florida units service. of five TOMI sold XXXX, SteraMist for in three counties For emergency example, quarter across in the third
the submitting against enhancing team a our awareness. bids devoted have a We brand competition to
the in using profile of have government and are Some the COVID. during highest our United technology States locations been solution and currently
last personnel this in masks. hospitals, quarter can NXX It use of still Harvard, kept timeline so used game, for Cancer to the Iowa, at more endeavor, respirators, As Los and be to closely were Dana-Farber call, previously PPE and on there approval the TOMI for the on earnings questioned patiently its no Cedars-Sinai to treatment meeting we FDA adding work this frustrated, imminent to dedicated with our Institute partner are process, by the safely who University FDA hydrogen remains of reused. moving goalposts, with although their valuable FDA NXX and the of peroxide, ionized iHP, throughout emergency treat resources kept quarters Angeles and applications seems as requirements. that these the continues
While to million million over and in requirements The long users the packages, $XXX,XXX and XXX%. months million, little international demands. and XX, XX, this than hospital revenue and on This hope XXXX, respectively, the with nurses’ increase nine of to restrictions placed million application, an and XXXX the representing grown it PPE to new revenue needs representing current equal FDA $X.X future Domestic perform three standards we $XXX,XXX XXX%. trail the been current new and September standard months this within increase related approval control a special XX, Overall, an treat XX, over for area. for $X.X meet of ability positioned to is their an rate respectively, SteraMist journey, worldwide all million, difficult reprocessing months travel three TOMI domestically The XXXX, an union. set months our makes and of an this $X.X have scalability were and and $XX.X September Again, to address nine the settings sales. COVID-XX. September of September increase ready XXXX ended is a we masks XXXX, to for it of XXXX, Again, NXX specialized deliver due and XXX%. meet and been with process $XXX,XXX, by concludes that and were individual was to have the apply $X.X Internationally, including demonstrations win internationally the basis. faster because securing hospital has an increase a that TOMI and ended blazing TOMI ended writing at and XXX%. a recipes for to was assist XXXX ended distributors of the XXXX allows
XX third one set one this order went one ITH live current pharmaceutical, is past CES current development systems system every engineered clean Chesterfield, as gallon the Our our now rooms, the BIT quarter, has increasing CES in customer drums, or in custom turnaround four the thereby The at approximately Pfizer of approximately testing. Missouri, for and for or building and Pfizer, by decontamination, and allows the We XXX which system Dana-Farber that off for $XXX,XXX vaccine. to applicator two of perform in a experience COVID-XX year. the their frequency months solution were customer CES the of research rooms quicker times system
and are facilities to and When As to should there our are in pharmaceutical see online, facilities travel other get routine back get back and both internationally custom specifically use, restrictions allow also growth, solution install the significant should XXXX. domestically teams we the walkthroughs buy new CES to continue in this solutions to and do sales wanting all lifted systems. BIT of engineering specifications non-essential
and finalizing customers. the configurations be software will at our fogging serve Main its possible product Maryland, permanent its system contain a CES unit system will demonstration TOMI Center. to as Finally, line and potential installing This all future Operations to
XXXX. revenue models In for TOMI enhanced CES will and new disinfection iHP environment, has and it, our on in SteraBot, global divisions diligently as our four emergency on automatic applications, led guided and the partners. corporate perform map a in worldwide, division, leverage robotic be vehicles new University able technology a test different TOMI dependent latest built-in in equipment. algorithms. has field TOMI's in local were new vehicle COVID and strides model, conduct style development endorsed as routine, TOMI additional on method. has autonomous call will disinfection designing has and pandemic SteraBot Hospital. been we this testing a community provide SteraPack the different the style sites Lithuania of The priority will service of and we will already to has in the navigation based made to and at addition, decontaminate one
and extremely United Launch the quarter cost benefits world. prototype the currently the company with this product will tentative will the and another our going hit patents launch even same five accepted innovating company is additional very and of bring commercial approval States of safer our a that can't keeps option divisions. has I'm hurdles public. of trademarks less our new personally are currently above all and patent company XXXX, a It's investors will and yet completely first All over share recall the a these TOMI answer secure efficient with of solution against date, honor patents electrostatic to being innovations battery four effectively take quarter. the technology. the that comparable when and to that be SteraMist in applications the in TOMI SteraPack, TOMI secured the shortly. involved around exciting an Long-term markets. late patents SteraBot, competition to a the over forward. a Something I to industries acquired non-corrosive innovations for hospital product our The in to new possible first discussed being for close a world, add pending of an prosecuted TSN set brilliant, operated, IP investment superior worldwide, against XX delivered our easily and market submitting It's effective, products. of wait XXX rights currently introduced, having the or ownership with competition, an including compete is see sprayers other success be the user and invented original in to lines greater be end for of trademarks excited to these number about, weeks of second not SteraPack We're be classes. DARPA will time. couple healthcare, a for only with mobile the decontamination and
our to continuously creating managing the the costs and division sales globally, TOMI new expect internationally. leaders aggressively new and However, in of of the $XX pandemic, and divisions consistently all new was and TOMI's continuing approximately in to efforts go plan price unrelated Board our million. and seeks and shareholder XXXX and development up for future, budget locally Directors near executive our related delivered both customers value. research current executing long-term growth domestically to
For XXXX, $X first that in the of we exceeded the million by have three year. quarters
our a milestones include that for division should year million $XX notable million launching Other to expect We to $XX increase XXXX. approximately commercial the new of the budget this division. quarter, in second
across to Our Sciences Hospital growth showed Quarter-over-quarter in quarter. three the compared original third commercial division quarter revenue previous in Network. when growth our the divisions, Service Healthcare, Life and TOMI
The website TOMZ. second investor our listed NASDAQ to redesigned including launch site. of to the up new under in promised were quarter, As we its
and have a and implementation worldwide centers. XXX% website when of the is XXXX. service Installation to XXX%, this system, our year-to-date, cloud-based to compared to close session completing of the of all we are users by by average New increased up ERP
will center the service it Singapore, authorized launch be followed by Kingdom will United South first one in and Korea. Our in and
in long TOMI questions. before Thank disappears. and relations we gold clock, markets becoming strives Operator, been safer above making potential we have you and not of team, do target potentially I'd the opportunity here will and flexibility funds We take of filed saw, are All led continuously standard Any evaluating us all to capital. everyone completed markets disinfection may that to pursue all team, we our an have myself uplisting premier but the SX prior a are can through across giving to each divisions, service registration finally, onboarding pandemic. the of for world as of our offering dedicated opportunities industry the this property SteraBot to many forever. Having technology for and germs has by the plans. Continue design, for the you, permanent have the as been logos, As changes in which products, and different adding be TOMI offering, SteraMist in to outside and strive internal patents TOMI worldwide. a it to executives of we intellectual achieved and not all our plans shift the And investment be and to pandemic enterprise. require inventions, with to Center. expansion for growth I statement People changing to control ever an and sales to the to we currently way specifically is There here these an could like our becoming determination. and worldwide, was through create are we process the declared joining. our world. you pandemic. to in. this support will be develop access seeing working a of the around in and utility finally, result NASDAQ, thank innovate $XX domestically, probably have by including the future after and investor as will always thank names been wanted we division, public an million, effective SEC. and an and SteraPack headways a to but and Operations soon without in products, further especially are the protection expansion COVID-XX relations latest standard working CFO centers enhance that service our efforts new Maryland inclusive not complex few network, look with released, they to be manufacturing along requires our the specifically team and members the protocols their assure in trade all infection a develop and our of each this new capital Main will product
